Publicaciones en colaboración con investigadores/as de Novartis (Sweden) (1)

2015

  1. A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients

    Annals of Oncology, Vol. 26, Núm. 10, pp. 2085-2091